The usefulness of fused MRI and SPECT images for the voxel positioning in proton magnetic ersonance spectroscopy and planning the biopsy of brain tumors: Presentation of the method;Przydatność obrazów fuzyjnych rezonansu magnetycznego i tomografii emisyjnej pojedynczego fotonu do pozycjonowania obszaru zainteresowania w protonowej spektroskopii rezonansu magnetycznego i planowania biopsji nowotworów mózgu pochodzenia glejowego - Prezentacja metody

Neurologia i Neurochirurgia Polska

Volumn 40, Issue 4, 2006, Pages 284-290

  Gajewicz, Witold ^a   Grzelak, Piotr ^a   Górska Chrzastek, Magdalena ^a   Zawirski, Marek ^a   Kuśmierek, Jacek ^a   Stefańczyk, Ludomir ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

1H 1MRS; Image fusion; MRI; SPECT

Indexed keywords

GADOLINIUM; IODINE 131; METIROSINE;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN METABOLISM; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MALE; METABOLIC RATE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLANNING; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PROCEDURES; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BIOPSY; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; METHYLTYROSINES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33749360407     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chan A.A., Lau A., Pirzkall A. i wsp. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma. J Neurosurg 2004; 101: 467-475.
2. Cattaneo G.M., Reni M., Rizzo G. i wsp. Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR (pre-operative) images on treatment planning CT scans. Radiother Oncol 2005; 75: 217-223.
3. Grosu A., Weber W., Feldmann H.J. i wsp. Fast experience with I-123-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys 2000; 47: 517-526.
4. Alger J.R., Frank J.A., Bizzi A. i wsp. Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 Fluorodeoxyglucose PET. Radiology 1990; 177: 633-641.
5. Ogawa T., Inugami W., Hatazawa J. i wsp. Clinical positron emission tomography for brain tumors: comparison of Fludeoxyglucose F18 and L-Methyl-11C-methionine. Am J Neuroradiol 1996; 17: 345-353.
6. Alger J.R., Cloughesy T.F. Structural and functional imaging of cerebral neoplasia. W: Mazziotta J. C., Toga A. W., Frackowiak R. S. [red.]. Brain mapping the disorders. Academic Press, San Diego 2000, ss. 387-416.
7. Rutkowski T., Tarnawski R., Sokół M. i wsp. 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 2003; 56: 1381-1389.
8. Ricci P.E., Pitt A., Keller P.J. i wsp. Effect of voxel position on single voxel MR spectroscopy findings. Am J Neuroradiol 2000; 21: 367-374.
9. Chrzastek-Górska M., Grzelak P., Bieńkiewicz M. i wsp. Assessment of clinical usefulness of 123I-alfa-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas. Nucl Med Rev 2004; 7: 135-141.
10. Meyer C., Boes J., Kim B. i wsp. Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1997; 1: 195-206.
11. Colin A. Boire J.Y. MRI-SPECT fusion for the synthesis of high resolution 3D functional brain images: a preliminary study. Comput Methods Programs Biomed 1999; 60: 107-116.
12. Friston K.J., Holmes A.P., Worsley K.J. i wsp. Statistical Parametric Maps in functional imaging: a general approach. Human Brain Mapping 1995; 2: 189-210.
13. Stokking R., Zuiderveld K.J., Hulshoff Pol H.E. i wsp. Normal fusion for three-dimensional integrated visualization of SPECT and magnetic resonance brain images. J Nucl Med 1997; 38: 624-629.
14. Vikhoff-Baaz B., Bergh A.C., Starck G. i wsp. A new set of fiducial markers for MRI, CT and SPET alignment. Nucl Med Commun 1997; 18: 1148-1154.
15. Wells III W.M., Viola P., Atsumi H. i wsp. Multi-modal volume registration by maximization of mutual information. Medical Images Analysis 1996; 1: 35-51.
16. Todd-Pokropek A. Advances in computers and image processing with applications in nuclear medicine. Q J Nucl Med 2002; 46: 62-69.
17. Bobek-Billewicz B., Jurkowski M. K., Romanowicz G. Usefulness of FDG-PET for the diagnosis of brain tumors. Przegl Lek 2005; 62: 54-60.
18. Lichy M.P., Henze M., Plathow C. i wsp. Metabolic imaging to follow stereotactic radiation of gliomas - the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT Rofo 2004; 176: 1114-1121.
19. Minn H., Joensun H., Ahonen A. i wsp. Fluorodeoksyglucose imaging: a method of assess the proliferative activity of human cancer in vivo. Cancer 1988; 61: 1776-1781.
20. Tarnawski R., Sokół M., Pieniazek P. i wsp. 1H MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002; 52: 1271-1276.
21. Walecki J., Sokół M., Pieniazek P. i wsp. Role of short TE 1H MR spectroscopy in monitoring of post-operation irradiated patients. Eur J Radiol 1999; 30: 154-161.
22. Vikhoff-Baaz B., Ljungberg M., Starck G. i wsp. Performance of 2D 1H spectroscopic imaging of the brain: some practical considerations regarding the measurement procedure. Magn Reson Imaging 1999; 17: 919-931.